SMTL ID : 8cxc.1

Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 4.31 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

None

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH

Citation

Lin, I. et al., Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics. Front. Drug Discov. (2023)

Release Date

2023-06-07

Peptides

3F2 Antibody light chain: A
3F2 Antibody heavy chain: B
Mesothelin, cleaved form: C
scFv Amatuximab: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
M

D
A

3F2 Antibody light chain

3F2 Antibody heavy chain

Mesothelin, cleaved form

scFv Amatuximab

Related Entries With Identical Sequence